The Ministry of Health, in collaboration with the World Health Organization (WHO) conducts advanced clinical studies, in seven different centers, at the several hospitals, across the Kingdom, to combat novel Coronavirus. The process have been launched, coincidently, at King Faisal Specialist Hospital, at the Medical City of King Saud University, at Prince Mohammed bin Abdulaziz Hospital, all in Riyadh, at Uhud Hospital, in Madinah, at Nur Hospital, in Makkah as well as at Dammam Central Hospital and Qatif Central Hospital, in the Eastern Region. The medical team, comprising physicians, pharmacists and researchers are aiming at assessing four remedy protocols that include Hydroxychloroquine lopinavir/Ritonavir Remedisivir Interferon. These drugs have anti-viral properties or imitate some of virus immunity response techniques and are given orally or through the vein as the study is focusing on those showing medium to strong symptoms and that these drugs have proven preliminary effectiveness, during the laboratory studies. Launching the study today was asserted by the General Department for Research and Studies, as some who have been contracting the virus were admitted as inmates, simultaneously, with the beginning of the clinical experiment. The project shed light on the limitless efforts exerted by the Government of the Kingdom and the full support of the Custodian of the Two Holy Mosques King Salman bin Abdulaziz Al Saud and HRH Crown Prince, as they spare no endeavor to find effective vaccine to the pandemic, to maintain the safety and hygiene of citizens and residents, living on the motherland soils.
